ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
36.95
-1.74 (-4.50%)
Apr 18, 2025, 3:04 PM CST
SHE:300723 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 17, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Market Capitalization | 16,592 | 13,394 | 9,894 | 10,200 | 6,339 | 6,181 | Upgrade
|
Market Cap Growth | -30.46% | 35.38% | -3.00% | 60.89% | 2.56% | 43.43% | Upgrade
|
Enterprise Value | 17,705 | 13,988 | 10,650 | 10,763 | 6,181 | 5,890 | Upgrade
|
Last Close Price | 36.95 | 29.55 | 22.74 | 23.45 | 14.51 | 13.78 | Upgrade
|
PE Ratio | - | 72.55 | 34.04 | 33.23 | 28.10 | 43.02 | Upgrade
|
Forward PE | - | 33.61 | 33.61 | 33.61 | 33.61 | 33.61 | Upgrade
|
PS Ratio | 8.76 | 5.35 | 4.34 | 4.64 | 3.78 | 3.78 | Upgrade
|
PB Ratio | 7.43 | 5.16 | 4.57 | 5.05 | 4.24 | 4.61 | Upgrade
|
P/TBV Ratio | 9.54 | 6.49 | 6.27 | 7.27 | 5.34 | 6.09 | Upgrade
|
P/FCF Ratio | - | 108.38 | - | - | - | 35.24 | Upgrade
|
P/OCF Ratio | - | 29.24 | 20.81 | 23.28 | 23.03 | 22.03 | Upgrade
|
EV/Sales Ratio | 9.35 | 5.59 | 4.67 | 4.89 | 3.69 | 3.60 | Upgrade
|
EV/EBITDA Ratio | 74.16 | 36.45 | 29.06 | 35.20 | 27.47 | 29.11 | Upgrade
|
EV/EBIT Ratio | - | 60.99 | 36.15 | 42.00 | 33.52 | 35.84 | Upgrade
|
EV/FCF Ratio | -42.57 | 113.18 | - | - | - | 33.58 | Upgrade
|
Debt / Equity Ratio | 0.77 | 0.31 | 0.54 | 0.61 | 0.19 | 0.15 | Upgrade
|
Debt / EBITDA Ratio | 7.23 | 1.97 | 2.98 | 3.73 | 1.29 | 0.98 | Upgrade
|
Debt / FCF Ratio | - | 6.49 | - | - | - | 1.13 | Upgrade
|
Asset Turnover | 0.42 | 0.59 | 0.58 | 0.75 | 0.85 | 0.92 | Upgrade
|
Inventory Turnover | 1.90 | 1.81 | 2.05 | 2.86 | 3.11 | 4.63 | Upgrade
|
Quick Ratio | 0.73 | 0.62 | 0.93 | 1.13 | 1.85 | 2.81 | Upgrade
|
Current Ratio | 1.05 | 0.91 | 1.17 | 1.30 | 2.17 | 3.07 | Upgrade
|
Return on Equity (ROE) | -15.28% | 6.37% | 12.53% | 16.70% | 15.77% | 10.80% | Upgrade
|
Return on Assets (ROA) | -0.02% | 3.37% | 4.71% | 5.45% | 5.85% | 5.75% | Upgrade
|
Return on Capital (ROIC) | -0.03% | 4.26% | 5.59% | 6.37% | 6.93% | 6.59% | Upgrade
|
Return on Capital Employed (ROCE) | - | 7.90% | 10.20% | 10.20% | 11.60% | 11.70% | Upgrade
|
Earnings Yield | -207.26% | 1.38% | 2.94% | 3.01% | 3.56% | 2.32% | Upgrade
|
FCF Yield | -250.69% | 0.92% | -1.32% | -1.21% | -0.61% | 2.84% | Upgrade
|
Dividend Yield | 56.83% | 0.71% | 0.59% | 0.57% | 0.64% | 0.54% | Upgrade
|
Payout Ratio | - | 35.77% | 21.88% | 12.90% | 16.33% | 24.98% | Upgrade
|
Buyback Yield / Dilution | -205.30% | -1.62% | -1.94% | 2.20% | -0.64% | 1.08% | Upgrade
|
Total Shareholder Return | -148.47% | -0.91% | -1.35% | 2.77% | -0.00% | 1.62% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.